説明
Urgency symptom improvements in IBS-D patients are documented across treatment timepoints for both study arms.
Figure 13
ChartSource Paper
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …Cite This Figure
![Figure 13: Urgency symptom improvements in IBS-D patients are documented across treatment timepoints for both study arms.]() > Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)
<figure> <img src="" alt="Urgency symptom improvements in IBS-D patients are documented across treatment timepoints for both study arms." /> <figcaption>Figure 13. Urgency symptom improvements in IBS-D patients are documented across treatment timepoints for both study arms.<br> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption> </figure>
関連するエビデンス
B
Bifidobacterium longum : Irritable Bowel Syndrome (IBS)
B
グレード B · 4 件の研究
Galactooligosaccharides (GOS) : Irritable Bowel Syndrome (IBS)
B
グレード B · 3 件の研究
Lactobacillus acidophilus : Irritable Bowel Syndrome (IBS)
D
グレード B · 3 件の研究
Fructooligosaccharides (FOS) : Irritable Bowel Syndrome (IBS)
グレード D · 2 件の研究